Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

C5 Lenalidomide

Copy Product Info
🥰Excellent
Catalog No. T9270Cas No. 191732-70-4

C5 Lenalidomide is an chemical weith inconclusive biological activity.

C5 Lenalidomide

C5 Lenalidomide

Copy Product Info
🥰Excellent
Purity: 99.4%
Catalog No. T9270Cas No. 191732-70-4
C5 Lenalidomide is an chemical weith inconclusive biological activity.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
25 mg$33In StockIn Stock
50 mgPreferentialIn StockIn Stock
1 mL x 10 mM (in DMSO)$29In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.4%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

C5 Lenalidomide AI Summary
C5 Lenalidomide exhibits significant bioactivities, including anti-inflammatory activity in human peripheral blood mononuclear cells (PBMCs). Specifically, it inhibits the lipopolysaccharide-stimulated release of TNF-alpha at a concentration of 100 µM, achieving a reduction of 15.0%. An assay using enzyme-linked immunosorbent assay (ELISA) indicated that C5 Lenalidomide has an IC50 value greater than 100,000.0 nM for reducing LPS-induced TNF-alpha production in these cells. Additionally, it displaces fluorescent tracers from NanoLuc-tagged CRBN in a NanoBRET assay with an IC50 of 382.0 nM. In human MOLT-4 cells, C5 Lenalidomide demonstrates Protac activity by inducing the degradation of IKZF1 with a maximum reduction of 15.0% after 24 hours and a DC50 greater than 10.0 µM for this degradation..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
C5 Lenalidomide is an chemical weith inconclusive biological activity.
Chemical Properties
Molecular Weight259.26
FormulaC13H13N3O3
Cas No.191732-70-4
SmilesO=C1N(CC=2C1=CC=C(N)C2)C3C(=O)NC(=O)CC3
Relative Density.1.460 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 50 mg/mL (192.86 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.8571 mL19.2857 mL38.5713 mL192.8566 mL
5 mM0.7714 mL3.8571 mL7.7143 mL38.5713 mL
10 mM0.3857 mL1.9286 mL3.8571 mL19.2857 mL
20 mM0.1929 mL0.9643 mL1.9286 mL9.6428 mL
50 mM0.0771 mL0.3857 mL0.7714 mL3.8571 mL
100 mM0.0386 mL0.1929 mL0.3857 mL1.9286 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy C5 Lenalidomide | purchase C5 Lenalidomide | C5 Lenalidomide cost | order C5 Lenalidomide | C5 Lenalidomide chemical structure | C5 Lenalidomide formula | C5 Lenalidomide molecular weight